Thyroid Cancer
Thyroid cancer is a disease in which cancer cells form in the tissues of the thyroid gland. Thyroid nodules are common, but usually are not cancerous. If the nodule is cancerous, thyroid cancer cells can spread into normal thyroid tissue and nearby blood and lymph vessels.
The most common types of thyroid cancer are papillary and follicular. Other less common types include medullary and anaplastic thyroid cancer. Thyroid cancer often has no symptoms, but it may be identified by swollen lymph nodes, painful or difficult swallowing, or a lump at the base of the neck.
Lurie Cancer Center’s multidisciplinary team of specialists are experts in the diagnosis, staging and treatment of every type of thyroid cancer.
Learn More About
Our Experts
Working together, our multidisciplinary team of specialists create a personalized treatment plan, providing comprehensive, state-of-the-art cancer care and patient-centered support.
Clinical Trials
Through clinical trials, our patients gainaccess to promising new treatment options before they are widely available. At any given time, Lurie Cancer Center is conducting more than 500 clinical trials for nearly every type of cancer. Use the search tool below to view a list of innovative trials underway at the Lurie Cancer Center.
Patient Support
Lurie Cancer Center offers a wide range of specialized services and supportive care to help patients and families before, during and after cancer treatment.
Thyroid Cancer Clinical Trials
Talk with your care team to find out whether a clinical trial is right for you, including these innovative clincial trials to treat patients with thyroid cancer.
- Phase 2 study of XL092 as first line therapy in radioiodine refractory differentiated thyroid cancer
- DRUG TP-CA-006: TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head & Neck Squamous Cell Carcinoma (HNSCC)
- (xIRB NCI CIRB) ECOG-ACRIN 3231: A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600E